Although high S100A2 expression represents an independent predictor of survival in patients with pancreatic cancer, patients with S100A2-negative tumors present favorable survival as patients undergoing pancreatectomy, even in the presence of involved positive surgical margins or lymph node metastases in vivo [72]. Here, S100A2 is linked to pancreatic neoplasm.